Protocol Summary

Protocol No.: OCR14209

Sponsor Protocol No.: iCare

Study Title
iCare for Cancer Patients

Principal Investigator(s)
Cogle, Christopher

Objective
The purpose of this study is to use genomic information from individual patients to create simulation avatars that will be used to predict novel drug combinations with therapeutic potential.

Description
As part of normal clinical care, subjects will undergo peripheral blood draws and biopsies for disease assessment of their cancer. In cases of hematological malignancies, bone marrow aspiration & biopsy are routinely performed.

Results of testing and analysis will be provided to the treating providers. Treating providers may use these results at their discretion in the treatment of their patients.

Phase: NA

Age Group: Adult

Scope: Local

Treatment
This is an observational study.

Detailed Eligibility
Inclusion Criteria:
1. Ages 18 years old and older
2. Individuals known or suspected of having a blood cancer or hematologic disorder
3. Capable of providing informed consent.

Applicable Disease Sites
Hematologic / Bone Marrow Diseases
Leukemia
Multiple Myeloma
Myelodysplastic Syndrome (MDS)

Participating Institutions
UF Gainesville : Christina Cline

Contact
Christina Cline, RN
Phone: +1 352-273-6840

Email: clcline@ufl.edu

More Information:
View study listing on ClinicialTrials.gov
http://www.clinicaltrials.gov/ct2/show/
NCT02435550